What rheumatologists should know about complying with the PPSA when it goes into effect on August 1
Search results for: hospital
Rheuminations: Fraud Casts a Pall on Medical Research
The history, causes, and effects of scientific misconduct and strategies to reduce fraud and plagiarism in clinical medicine
How Rheumatologists Can Connect with Congress during August Recess
Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices
Rheumatology Drug Research Should Focus on Particular Groups of Patients
An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment
California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients
A systemic lupus erythematosus (SLE) disease expert emphasizes benefits of hydroxychloroquine, burst of steroid treatments
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Tech Talk: Rheumatologists Have Many Options for Providing Patient Education Online
Services to provide and maintain patient-education segments of physicians’ websites become more sophisticated
What Rheumatologists Need to Know About the Physician Payment Sunshine Act
The federal act mandates transparency within physician–industry relationship
Researchers Explore HLA-B27’s Role in the Development of Spondylitis
New research reports on the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation. (posted June 27, 2013)
Can Lubricating Joints Prevent Osteoarthritis?
Proteoglycan 4 (Prg4), also known as lubricin, could slow the process of cartilage destruction in osteoarthritis. (posted June 13, 2013)
- « Previous Page
- 1
- …
- 276
- 277
- 278
- 279
- 280
- …
- 330
- Next Page »